Drug Pricing in 2026: Still Moving Up Even Under Pressure New data from 3 Axis Advisors shows that drugmakers are planning price increases on 350+ branded medications in 2026, up from ~250 at the same time last year
One such option is Mounjaro (tirzepatide), a once-weekly injectable medication that was originally approved for type 2 diabetes and is now FDA-approved for weight management in adults with obesity or overweight and at least one weight-related health condition
We dug into the science page (lol), the founder-funded studies, the $250 price tag for what amounts to soup, olive oil, almonds, and herbal tea, and the $20 jar of "longevity Nutella" they sell on the side
A distinguishing feature of TB-500 is its anti-fibrotic activity
( I ) Ratio of GSR/GPX4 at protein level by Western blot was calculated in control and A2ARi-treated groups
This process bypasses some of the damaged metabolic pathways, allowing the cells to resume beta-oxidation and produce life-sustaining ATP